Clinical trial
Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery…
NCT00335543 · Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen Krebsgesellschaft, Other · Completed
Key facts
| NCT number | NCT00335543 |
|---|---|
| Title | Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery |
| Official title | Preoperative Chemoradiation in Locally Resectable Adenocarcinoma of Pancreatic Head Without Metastasis |
| Lead sponsor | Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen Krebsgesellschaft, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, gemcitabine hydrochloride, adjuvant therapy, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 254 |
| Start date | Jun 1, 2003 |
| Primary completion | Jun 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Jun 12, 2006 |
| Last update posted | Aug 12, 2013 |
| Countries | Austria, Germany, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: